New Label For Evicel Fibrin Sealant Could Boost Omrix/Ethicon Market Share

Omrix Biopharmaceuticals plans with the help of marketing partner Johnson & Johnson/Ethicon to take a larger share of the U.S. hemostasis market now that its Evicel fibrin sealant is approved for all types of surgery

More from Archive

More from Medtech Insight